会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD AND KIT FOR ANALYTE DETERMINATION AT ACIDIC CONDITIONS
    • 酸性条件下分析测定方法和试剂盒
    • US20150268238A1
    • 2015-09-24
    • US14433276
    • 2013-10-03
    • GYROS Patent AB
    • Mats InganäsPirjo Lehtonen
    • G01N33/543
    • G01N33/54393G01N33/5306G01N33/5375G01N2333/195
    • A method of quantitatively determining an analyte in a fluid sample by an immunoassay comprises binding of the analyte to a ligand capable of specifically binding to the analyte, wherein at least part of the analyte is present as an analyte complex is disclosed. The method comprises the steps of: a) subjecting the sample to a first acidic pH to at least substantially dissociate any analyte complex present and provide substantially all analyte in free form, b) raising the first acidic pH to a second acidic pH where re-formation of complexes is prevented but where binding of analyte to the ligand is permitted, and c) determining the binding of analyte to the ligand to quantitatively determine the analyte in the sample.
    • 通过免疫测定定量测定流体样品中的分析物的方法包括将分析物结合到能够特异性结合分析物的配体,其中至少部分分析物作为分析物复合物存在。 该方法包括以下步骤:a)使样品经受第一酸性pH至少基本上解离所存在的任何分析物复合物,并基本上提供游离形式的所有分析物,b)将第一酸性pH提高至第二酸性pH, 防止复合物的形成,但是其中允许分析物与配体的结合,和c)测定分析物与配体的结合以定量测定样品中的分析物。
    • 4. 发明申请
    • IMMUNOLOGICAL METHOD
    • 免疫学方法
    • US20160097777A1
    • 2016-04-07
    • US14849326
    • 2015-09-09
    • GYROS Patent AB
    • Cecilia BillAnn-Charlott SteffenMats Inganäs
    • G01N33/68
    • G01N33/6854G01N33/94
    • The present invention relates to an in vitro method for the detection of an anti-drug antibody (ADA) against a therapeutic drug antibody (TDA) in a biological sample. The in vitro method comprises detecting and capturing said ADA using affinity moieties obtained from an intact therapeutic drug antibody, or a Fab fragment thereof, in a certain manner. Avoiding using only intact therapeutic drug antibodies or only Fab fragments thereof as reagents in such a method has been proven as an efficient way of increasing sensitivity, decreasing unspecific binding and the formation of large protein complexes. Such a method has great utility in therapeutic drug development or in the evaluation of a particular treatment of a patient.
    • 本发明涉及用于检测针对生物样品中治疗药物抗体(TDA)的抗药物抗体(ADA)的体外方法。 体外方法包括使用从完整治疗药物抗体或其Fab片段获得的亲和部分以某种方式检测和捕获所述ADA。 已经证明避免在这种方法中仅使用完整的治疗药物抗体或其Fab片段作为试剂,这是提高灵敏度,减少非特异性结合和形成大蛋白复合物的有效途径。 这种方法在治疗药物开发或评估患者的特定治疗方面具有很大的用途。